Header Logo

Connection

Christopher Otis to Female

This is a "connection" page, showing publications Christopher Otis has written about Female.
Connection Strength

0.451
  1. Ersoy E, Cao QJ, Otis CN. HER2 Protein Overexpression and Gene Amplification in Tubo-Ovarian High-grade Serous Carcinomas. Int J Gynecol Pathol. 2022 07 01; 41(4):313-319.
    View in: PubMed
    Score: 0.042
  2. Bhele S, Stoddart L, Petersen C, Baum J, Otis CN. Parasitic Microcalcifications of the Breast. Int J Surg Pathol. 2020 Sep; 28(6):645-646.
    View in: PubMed
    Score: 0.037
  3. Prieto-Granada C, Setia N, Otis CN. Lymph node extramedullary hematopoiesis in breast cancer patients receiving neoadjuvant therapy: a potential diagnostic pitfall. Int J Surg Pathol. 2013 Jun; 21(3):264-6.
    View in: PubMed
    Score: 0.023
  4. Kuperman M, Florence RR, Pantanowitz L, Visintainer PF, Cibas ES, Otis CN. Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: an evidence-based approach. Diagn Cytopathol. 2013 Feb; 41(2):131-40.
    View in: PubMed
    Score: 0.021
  5. Camelo-Piragua SI, Habib C, Kanumuri P, Lago CE, Mason HS, Otis CN. Mucoepidermoid carcinoma of the breast shares cytogenetic abnormality with mucoepidermoid carcinoma of the salivary gland: a case report with molecular analysis and review of the literature. Hum Pathol. 2009 Jun; 40(6):887-92.
    View in: PubMed
    Score: 0.018
  6. Caponetti GC, Pantanowitz L, Marconi S, Havens JM, Lamps LW, Otis CN. Evaluation of immunohistochemistry in identifying Bartonella henselae in cat-scratch disease. Am J Clin Pathol. 2009 Feb; 131(2):250-6.
    View in: PubMed
    Score: 0.018
  7. Pantanowitz L, Otis CN. Cystitis glandularis. Diagn Cytopathol. 2008 Mar; 36(3):181-2.
    View in: PubMed
    Score: 0.016
  8. Assaad MW, Pantanowitz L, Otis CN. Diagnostic accuracy of image-guided percutaneous fine needle aspiration biopsy of the mediastinum. Diagn Cytopathol. 2007 Nov; 35(11):705-9.
    View in: PubMed
    Score: 0.016
  9. Pantanowitz L, Otis CN. Myxoid liposarcoma. Diagn Cytopathol. 2007 May; 35(5):283-4.
    View in: PubMed
    Score: 0.016
  10. Crisi GM, Pantanowitz L, Otis CN. Images in pathology. Mammotome footprints: histologic artefacts in the era of stereotactic vacuum mammotome biopsy. Int J Surg Pathol. 2006 Jul; 14(3):221-2.
    View in: PubMed
    Score: 0.015
  11. Otis CN, Moral LA. Images in pathology: granule cell loss in AIDS-associated progressive multifocal leukoencephalopathy. Int J Surg Pathol. 2005 Oct; 13(4):360.
    View in: PubMed
    Score: 0.014
  12. Pantanowitz L, Florence RR, Goulart RA, Otis CN. Trichomonas vaginalis P16 Immunoreactivity in cervicovaginal Pap tests: a diagnostic pitfall. Diagn Cytopathol. 2005 Sep; 33(3):210-3.
    View in: PubMed
    Score: 0.014
  13. Powell JL, Otis CN. Commenting on "Vulvar langerhans cell histocytosis: a case report and review of the literature" by Santillan et al. 91:241-246. Gynecol Oncol. 2004 Jun; 93(3):719; author reply 719.
    View in: PubMed
    Score: 0.013
  14. Seliem RM, Assaad MW, Gorombey SJ, Moral LA, Kirkwood JR, Otis CN. Fine-needle aspiration biopsy of the central nervous system performed freehand under computed tomography guidance without stereotactic instrumentation. Cancer. 2003 Oct 25; 99(5):277-84.
    View in: PubMed
    Score: 0.012
  15. Otis CN, Krebs PA, Albuquerque A, Quezado MM, San Juan X, Sobel ME, Merino MJ. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features. Int J Surg Pathol. 2002 Oct; 10(4):237-45.
    View in: PubMed
    Score: 0.011
  16. Park KJ, Selinger CI, Alvarado-Cabrero I, Duggan MA, Kiyokawa T, Mills AM, Ordi J, Otis CN, Plante M, Stolnicu S, Talia KL, Wiredu EK, Lax SF, McCluggage WG. Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol. 2022 Nov 01; 41(Suppl 1):S64-S89.
    View in: PubMed
    Score: 0.011
  17. El Hallani S, Arora R, Lin DI, M?sb?c A, Mateoiu C, McCluggage WG, Nucci MR, Otis CN, Parkash V, Parra-Herran C, Longacre TA. Mixed Endometrioid Adenocarcinoma and M?llerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma. Am J Surg Pathol. 2021 03 01; 45(3):374-383.
    View in: PubMed
    Score: 0.010
  18. Acosta AM, Sholl LM, Cin PD, Howitt BE, Otis CN, Nucci MR. Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability. Histopathology. 2020 Nov; 77(5):788-797.
    View in: PubMed
    Score: 0.010
  19. Muse ME, Titus AJ, Salas LA, Wilkins OM, Mullen C, Gregory KJ, Schneider SS, Crisi GM, Jawale RM, Otis CN, Christensen BC, Arcaro KF. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization. Epigenetics. 2020 10; 15(10):1093-1106.
    View in: PubMed
    Score: 0.010
  20. Bean GR, Krings G, Otis CN, Solomon DA, Garc?a JJ, van Zante A, Camelo-Piragua S, van Ziffle J, Chen YY. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast. Histopathology. 2019 Feb; 74(3):463-473.
    View in: PubMed
    Score: 0.009
  21. Williams KE, Jawale RM, Schneider SS, Otis CN, Pentecost BT, Arcaro KF. DNA methylation in breast cancers: Differences based on estrogen receptor status and recurrence. J Cell Biochem. 2019 01; 120(1):738-755.
    View in: PubMed
    Score: 0.009
  22. McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L. Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol. 2018 May; 37(3):205-228.
    View in: PubMed
    Score: 0.008
  23. Longacre TA, Broaddus R, Chuang LT, Cohen MB, Jarboe EA, Mutter GL, Otis CN, Zaino RJ. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium. Arch Pathol Lab Med. 2017 11; 141(11):1508-1512.
    View in: PubMed
    Score: 0.008
  24. Ordulu Z, Nucci MR, Dal Cin P, Hollowell ML, Otis CN, Hornick JL, Park PJ, Kim TM, Quade BJ, Morton CC. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol. 2016 05; 29(5):500-10.
    View in: PubMed
    Score: 0.007
  25. Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. J Cell Physiol. 2014 Sep; 229(9):1160-9.
    View in: PubMed
    Score: 0.006
  26. Wang Y, Otis CN, Florence RR. Atypical squamous cells in the urine revealing endometrioid adenocarcinoma of the endometrium with squamous cell differentiation: a case report. Diagn Cytopathol. 2015 Jan; 43(1):49-52.
    View in: PubMed
    Score: 0.006
  27. Fagan-Solis KD, Schneider SS, Pentecost BT, Bentley BA, Otis CN, Gierthy JF, Arcaro KF. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. J Cell Biochem. 2013 Jun; 114(6):1385-94.
    View in: PubMed
    Score: 0.006
  28. McCluggage WG, Colgan T, Duggan M, Hacker NF, Mulvany N, Otis C, Wilkinson N, Zaino RJ, Hirschowitz L. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol. 2013 Jan; 32(1):45-65.
    View in: PubMed
    Score: 0.006
  29. Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics. 2011 Dec; 6(12):1425-35.
    View in: PubMed
    Score: 0.005
  30. Yan H, Blackburn AC, McLary SC, Tao L, Roberts AL, Xavier EA, Dickinson ES, Seo JH, Arenas RB, Otis CN, Cao QJ, Lawlor RG, Osborne BA, Kittrell FS, Medina D, Jerry DJ. Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice. Am J Pathol. 2010 Mar; 176(3):1421-32.
    View in: PubMed
    Score: 0.005
  31. Doldan A, Otis CN, Pantanowitz L. Adipose tissue: a normal constituent of the uterine cervical stroma. Int J Gynecol Pathol. 2009 Jul; 28(4):396-400.
    View in: PubMed
    Score: 0.005
  32. Pantanowitz L, Otis CN, Goulart RA. Cytologic findings of psammocarcinoma in peritoneal washings. Acta Cytol. 2009 May-Jun; 53(3):263-7.
    View in: PubMed
    Score: 0.004
  33. Pinco J, Goulart RA, Otis CN, Garb J, Pantanowitz L. Impact of digital image manipulation in cytology. Arch Pathol Lab Med. 2009 Jan; 133(1):57-61.
    View in: PubMed
    Score: 0.004
  34. Piragua SC, Otis CN, Prefontaine M, Pantanowitz L. Cystic struma ovarii (with macrocystic change). Int J Surg Pathol. 2008 Oct; 16(4):433-4.
    View in: PubMed
    Score: 0.004
  35. Pantanowitz L, Henneberry JM, Otis CN, Zakhary M. Adenolipoma of the external female genitalia. Int J Gynecol Pathol. 2008 Apr; 27(2):297-300.
    View in: PubMed
    Score: 0.004
  36. Hollowell ML, Goulart RA, Gang DL, Otis CN, Prior J, Sachs BF, Pantanowitz L. Cytologic features of m?llerian papilloma of the cervix: mimic of malignancy. Diagn Cytopathol. 2007 Sep; 35(9):607-11.
    View in: PubMed
    Score: 0.004
  37. Modem RR, Otis CN, Florence RR, Pantanowitz L. Intestinal type adenocarcinoma in situ of the cervix. Diagn Cytopathol. 2007 Sep; 35(9):584-5.
    View in: PubMed
    Score: 0.004
  38. Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, Nikolcheva T, Allard J, Peltz G, Otis CN, Cao QJ, Ricketts RS, Naber SP, Mollenhauer J, Poustka A, Malamud D, Jerry DJ. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol. 2007 Jun; 170(6):2030-41.
    View in: PubMed
    Score: 0.004
  39. Gozgit JM, Pentecost BT, Marconi SA, Otis CN, Wu C, Arcaro KF. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Mol Cancer Res. 2006 Dec; 4(12):905-13.
    View in: PubMed
    Score: 0.004
  40. Varnholt H, Otis CN, Nucci MR, Johari VP. Fallopian tube prolapse mimicking aggressive angiomyxoma. Int J Gynecol Pathol. 2005 Jul; 24(3):292-4.
    View in: PubMed
    Score: 0.003
  41. Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Cancer Res. 2004 Aug 01; 64(15):5140-7.
    View in: PubMed
    Score: 0.003
  42. Blackburn AC, Brown JS, Naber SP, Otis CN, Wood JT, Jerry DJ. BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice. Cancer Res. 2003 May 15; 63(10):2364-8.
    View in: PubMed
    Score: 0.003
  43. Hendsch SA, Glover SD, Otis CN, Donovan JT. Atypical glandular cells of undetermined significance from extramammary Paget's of the bladder. Obstet Gynecol. 2002 May; 99(5 Pt 2):912-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.